GLP-1RA non-responders: tackling a hidden challenge behind the obesity epidemic
In recent years, the notoriety and uptake of incretin-based therapies such as glucagon-like peptide-1 receptor agonists (GLP-1RAs) has skyrocketed, with…
Analysis
Stada Arzneimittel Supply Chain and Packaging Facility, Turda, Romania
Podcast: How Sandoz plans to harness its “golden decade”
The shrinking return on investment for Nordic innovation
EyePoint Pharmaceuticals cGMP Manufacturing Facility, US
Staunch biotech competition spurs new secretive tactics, shifts investor approach
